DWP-418

N/A

Report date: 2023/10/26 17:10:24

Base Information

Drug NameDWP-418
Drug Alias NameDWP418DWP 418Adenoviral gene therapy (Daewoong)DWP-418
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionImmunostimulantsTelomerase reverse transcriptase inhibitorsGene transference
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsHead and Neck NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A